Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61K Hold
67
﹤0.01% 521
2026
Q1
$2.67K Sell
67
-3
-4% -$142 ﹤0.01% 496
2025
Q4
$3.16K Hold
70
﹤0.01% 476
2025
Q3
$3.14K Hold
70
﹤0.01% 469
2025
Q2
$3.37K Buy
+70
New +$3.04K ﹤0.01% 429

Other funds holding QGEN

PFS Partners's QGEN Position: Q2 2026 in Review

PFS Partners held its Qiagen (QGEN) position steady in Q2 2026 at 67 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

PFS Partners first reported a position in QGEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.37K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • PFS Partners held 67 shares of Qiagen worth $2.61K as of Q2 2026.
  • PFS Partners left its Qiagen share count unchanged in Q2 2026.
  • Qiagen made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #521 holding.
  • PFS Partners first reported a position in Qiagen in Q2 2025 and has held it in 5 quarters since.
  • PFS Partners's Qiagen position peaked at $3.37K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.